Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
November 8, 2016
Academia and Government
November 4, 2016
Academia and Government
November 2, 2016
Academia and Government
October 27, 2016
Academia and Government
October 27, 2016
Academia and Government
October 25, 2016